More about

Antimalarial

News
January 20, 2021
3 min read
Save

Antimalarial adherence lowers risk for death by 83% in lupus

Patients with systemic lupus erythematosus who adhere to antimalarial therapy have a 71% lower risk for death than those in nonadherence, and an 83% lower risk than those who discontinue, according to data published in Arthritis Care & Research.

News
November 07, 2020
2 min read
Save

COVID-19 antimalarial shortages affected rheumatology patients’ physical, mental health

Antimalarial drug shortages due to COVID-19 affected more rheumatology patients in African and East Asian regions than those in the Americas and Europe, noted data from the COVID-19 Global Rheumatology Alliance Patient Experience Survey.

News
September 30, 2020
3 min read
Save

Smoking status, antimalarial use heavily influence cancer risk in SLE

Cancers — particularly lung cancer — were more likely to occur among patients with systemic lupus erythematosus who smoked, whereas use of antimalarials was linked to lower cancer risk, researchers noted.

News
June 10, 2020
2 min read
Save

Patients with SLE at higher risk for antimalarial-induced retinopathy

Patients with systemic lupus erythematosus had a significantly increased risk for antimalarial-induced retinopathy, possibly due to prolonged exposure to those drugs, according to a data presented at the EULAR 2020 E-Congress.

News
August 19, 2019
2 min read
Save

Treatment options for severe malaria ‘grim’ in US, clinicians urged to act

In a recent opinion piece published in Annals of Internal Medicine, two experts urged clinicians, hospitals, federal agencies and professional societies to work together to prevent “a catastrophe” related to severe malaria in the United States.